ELISpot and FluoroSpot Assay Market by Product (Assay Kit (T Cell and B Cell assay), Analyzer, Ancillary Products), Application (Transplants, Vaccine Development), End User (Hospitals & Clinical Labs, Research Institutes) - Global Forecast to 2027
Description
ELISpot and FluoroSpot Assay Market by Product (Assay Kit (T Cell and B Cell assay), Analyzer, Ancillary Products), Application (Transplants, Vaccine Development), End User (Hospitals & Clinical Labs, Research Institutes) - Global Forecast to 2027
The global ELISpot and FluoroSpot Assays market size is projected to reach USD 390 million by 2027 from USD 274 million in 2022, at a CAGR of 7.3% during the forecast period. Market is driven by factors such as Increasing use of ELISpot and FluoroSpot assays in oncology, growth in biotechnology and biopharmaceutical industries. On the other hand, availability of alternative detection technologies is expected to limit market growth to a certain extent in the coming years.
“The Assay kits accounted for the largest market share in the ELISpot and FluoroSpot Assays product’ market, during the forecast period”
The ELISpot and FluoroSpot Assay Products market is segmented into Assay kits, Analyzers, and Ancillary Products. In 2021, kits accounted for a sizable market share because they offer advantages in terms of high specificity and sensitivity and better detection limits as compared to other assays such as ELISA as well as their wide applications in the field of research and diagnostics.
“Diagnostic application segment accounted for the largest market share”
Based on type of application, the ELISpot and FluoroSpot Assays market is segmented into Diagnostic and Research Application. The Diagnostic application segment accounted for the largest market share in 2021., while research application is expected to grow at the fastest rate in the years ahead, from 2022 to 2027 considering their practice in several research applications, such as vaccine development, clinical trials, and cancer research.
“APAC region accounted for the highest CAGR”
The global ELISpot and FluoroSpot Assays market is divided into four regions: North America, Asia-Pacific, Europe, and Rest of the World. According to the regional analysis, the Asia-Pacific region is likely to retain a significant market share in 2021 and the future. The Asia-Pacific market is being propelled by an increase in non-communicable (NCD), research funding on vaccines and changing disease profiles. North America, on the other hand, will experience significant growth in the coming years due to the presence of key players, the availability of technologically advanced ELISpot and FluoroSpot assay kits and analyzers.
The primary interviews conducted for this report can be categorized as follows:
By Company Type: Tier 1 - 32%, Tier 2 - 44%, and Tier 3 - 24%
By Designation: C-level - 30%, D-level - 34%, and Others - 36%
By Region: North America - 40%, Europe - 28%, Asia Pacific - 20%, and the Rest of the World – 12%
Lits of Companies Profiled in the Report:
Oxford Immunotec (UK)
Cellular Technology Limited (US)
Mabtech (Sweden)
Becton, Dickinson and Company (US)
Abcam plc. (UK)
Bio-Techne. (US)
Mikrogen Diagnostik (Germany)
Autoimmun Diagnostika GmbH (Germany)
U-CyTech (Netherland)
Medix Biochemica (Finland)
Merck KGaA (Germany)
Bio-Sys GmbH (Germany)
Anogen-Yes Biotech Laboratories Ltd (Canada)
Abnova Corporation. (Taiwan)
Biorbyt Ltd (UK)
Research Coverage:
This report studies the ELISpot and FluoroSpot Assays market based on product, applications, End user, and region. The report also analyses factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total ELISpot and FluoroSpot Assays market. The report forecasts the revenue of the market segments with respect to four major regions.
Reasons to Buy the Report:
The report provides insights on the following pointers:
Market Penetration: Comprehensive information on ELISpot and FluoroSpot assay products offered by the top 25 players in the market. The report analyses the ELISpot and FluoroSpot Assays market by product, application, end user and region.
Market Development: Comprehensive information about lucrative emerging markets. The report analyses the markets for various securement devices across key geographic regions.
Market Diversification: Exhaustive information about untapped geographies, recent developments, and investments in the ELISpot and FluoroSpot Assays market
Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the ELISpot and FluoroSpot Assays market
Market Position: It will upkeep stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies.
The global ELISpot and FluoroSpot Assays market size is projected to reach USD 390 million by 2027 from USD 274 million in 2022, at a CAGR of 7.3% during the forecast period. Market is driven by factors such as Increasing use of ELISpot and FluoroSpot assays in oncology, growth in biotechnology and biopharmaceutical industries. On the other hand, availability of alternative detection technologies is expected to limit market growth to a certain extent in the coming years.
“The Assay kits accounted for the largest market share in the ELISpot and FluoroSpot Assays product’ market, during the forecast period”
The ELISpot and FluoroSpot Assay Products market is segmented into Assay kits, Analyzers, and Ancillary Products. In 2021, kits accounted for a sizable market share because they offer advantages in terms of high specificity and sensitivity and better detection limits as compared to other assays such as ELISA as well as their wide applications in the field of research and diagnostics.
“Diagnostic application segment accounted for the largest market share”
Based on type of application, the ELISpot and FluoroSpot Assays market is segmented into Diagnostic and Research Application. The Diagnostic application segment accounted for the largest market share in 2021., while research application is expected to grow at the fastest rate in the years ahead, from 2022 to 2027 considering their practice in several research applications, such as vaccine development, clinical trials, and cancer research.
“APAC region accounted for the highest CAGR”
The global ELISpot and FluoroSpot Assays market is divided into four regions: North America, Asia-Pacific, Europe, and Rest of the World. According to the regional analysis, the Asia-Pacific region is likely to retain a significant market share in 2021 and the future. The Asia-Pacific market is being propelled by an increase in non-communicable (NCD), research funding on vaccines and changing disease profiles. North America, on the other hand, will experience significant growth in the coming years due to the presence of key players, the availability of technologically advanced ELISpot and FluoroSpot assay kits and analyzers.
The primary interviews conducted for this report can be categorized as follows:
By Company Type: Tier 1 - 32%, Tier 2 - 44%, and Tier 3 - 24%
By Designation: C-level - 30%, D-level - 34%, and Others - 36%
By Region: North America - 40%, Europe - 28%, Asia Pacific - 20%, and the Rest of the World – 12%
Lits of Companies Profiled in the Report:
Oxford Immunotec (UK)
Cellular Technology Limited (US)
Mabtech (Sweden)
Becton, Dickinson and Company (US)
Abcam plc. (UK)
Bio-Techne. (US)
Mikrogen Diagnostik (Germany)
Autoimmun Diagnostika GmbH (Germany)
U-CyTech (Netherland)
Medix Biochemica (Finland)
Merck KGaA (Germany)
Bio-Sys GmbH (Germany)
Anogen-Yes Biotech Laboratories Ltd (Canada)
Abnova Corporation. (Taiwan)
Biorbyt Ltd (UK)
Research Coverage:
This report studies the ELISpot and FluoroSpot Assays market based on product, applications, End user, and region. The report also analyses factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total ELISpot and FluoroSpot Assays market. The report forecasts the revenue of the market segments with respect to four major regions.
Reasons to Buy the Report:
The report provides insights on the following pointers:
Market Penetration: Comprehensive information on ELISpot and FluoroSpot assay products offered by the top 25 players in the market. The report analyses the ELISpot and FluoroSpot Assays market by product, application, end user and region.
Market Development: Comprehensive information about lucrative emerging markets. The report analyses the markets for various securement devices across key geographic regions.
Market Diversification: Exhaustive information about untapped geographies, recent developments, and investments in the ELISpot and FluoroSpot Assays market
Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the ELISpot and FluoroSpot Assays market
Market Position: It will upkeep stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies.
Table of Contents
187 Pages
- STUDY OBJECTIVES
- MARKET DEFINITION
- MARKET SCOPE
- CURRENCY
- LIMITATIONS
- MARKET STAKEHOLDERS
- SUMMARY OF CHANGES
- RESEARCH DATA
- MARKET SIZE ESTIMATION
- MARKET BREAKDOWN AND DATA TRIANGULATION
- MARKET SHARE ANALYSIS
- STUDY ASSUMPTIONS
- RISK ASSESSMENT
- EXECUTIVE SUMMARY
- ELISPOT AND FLUOROSPOT ASSAYS MARKET OVERVIEW
- ELISPOT AND FLUOROSPOT ASSAY KITS MARKET, BY TECHNIQUE, 2022-2027
- NORTH AMERICA: ELISPOT AND FLUOROSPOT ASSAYS MARKET, BY PRODUCT AND COUNTRY (2022)
- ELISPOT AND FLUOROSPOT ASSAYS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
- INTRODUCTION
- MARKET DYNAMICS
- RANGES/SCENARIOS
- VALUE CHAIN ANALYSIS
- SUPPLY CHAIN ANALYSIS
- TECHNOLOGY ANALYSIS
- PORTER'S FIVE FORCES ANALYSIS
- KEY STAKEHOLDERS AND BUYING CRITERIA
- REGULATORY LANDSCAPE
- KEY CONFERENCES AND EVENTS IN 2022 AND 2023
- PATENT ANALYSIS
- PRICING ANALYSIS
- TRADE ANALYSIS
- ECOSYSTEM ANALYSIS
- TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
- INTRODUCTION
- ASSAY KITS
- ANALYZERS
- ANCILLARY PRODUCTS
- INTRODUCTION
- DIAGNOSTIC APPLICATIONS
- RESEARCH APPLICATIONS
- INTRODUCTION
- HOSPITAL AND CLINICAL LABORATORIES
- RESEARCH INSTITUTES
- BIOPHARMACEUTICAL COMPANIES AND CONTRACT RESEARCH ORGANIZATIONS
- INTRODUCTION
- NORTH AMERICA
- EUROPE
- ASIA PACIFIC
- REST OF THE WORLD
- OVERVIEW
- STRATEGIES ADOPTED BY KEY PLAYERS/RIGHT TO WIN
- REVENUE SHARE ANALYSIS
- MARKET SHARE ANALYSIS
- COMPANY EVALUATION QUADRANT
- COMPANY EVALUATION QUADRANT FOR SMES/STARTUPS
- FOOTPRINT ANALYSIS OF COMPANIES
- COMPETITIVE BENCHMARKING
- COMPETITIVE SCENARIO
- KEY PLAYERS
- OTHER PLAYERS
- INDUSTRY INSIGHTS
- DISCUSSION GUIDE
- KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
- CUSTOMIZATION OPTIONS
- RELATED REPORTS
- AUTHOR DETAILS
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
